Continental Chemicals Limited

Technology — Information Technology Services · BSE

₹54.85₹0.00 (0.00%)

DalalBaazaar Score

67 / 100

🟢 Good

Verdict

REASONABLE

Risk

Moderate

Driven by micro-cap size, which brings thin liquidity, falling profits.

In simple words: Reasonable but unspectacular business quality, but sales are shrinking. The direction of profits is the main factor to watch.

Decision support, not a buy or sell call.

As of 18 Oct 2026, 7:47 pm

Understanding the Business

Company site ↗

The 60-second version of Continental Chemicals Limited — what it does, how it earns, and who it competes with, before any of the numbers below.

What does this company do?

Continental Chemicals Limited engages in sale, purchase and licensing of Software in India and internationally. The company offers online solutions to the events industry.

IndustryInformation Technology Services

SectorTechnology

Employees8

Who are its competitors?

The closest listed comparisons in its industry are TATA CONSULTANCY SERV LT, INFOSYS LIMITED, HCL TECHNOLOGIES LTD, WIPRO LTD. These are the companies its valuation and returns are measured against elsewhere in this report.

Compared side by side in Peers ↓

What is its competitive advantage?Little sign of one

Returns on capital of the level reported are at or below what the capital likely costs. That is the financial pattern of a business competing largely on price, where advantage has to come from execution rather than position.

Peer median ROE32.0%

DalalBaazaar Score

67/ 100

Good

Weighted across six categories. Every point is explained below.

✗ Profit fell 20.3% in the latest year
• Not enough data to assess growth.

Quality vs. Valuation

Company Quality

70/ 100

Good

How good the business is, ignoring the share price entirely.

Valuation

59/ 100

Fair

What you are being asked to pay, ignoring how good the business is.

A reasonable business at a reasonable price — neither the quality nor the valuation stands out in either direction.

Historical Valuation

Current P/E

19.7x

Sector Median

16.5x

median of 4 sector peers

⚠️Against its sector it trades 19% above the peer median of 16.5x.

vs. its own history

Not enough price and earnings history

vs. sector peers

Fair

16.5x median of 4 peers · +19%

vs. generic bands

Fair

15x–35x

EV/EBITDA

—

PEG

—

Red Flags

No automated checks triggered

None of the automated financial checks below were triggered on the years of data available. That is not the same as a clean bill of health — see what could not be checked.

Investment Thesis

🟢 Bull CaseWhat could make this work?

No clear supporting case emerges from the available numbers.

🔴 Bear CaseWhat could go wrong?

Size brings its own risk
Micro Cap businesses are thinly traded, so exits are harder in a falling market and single events move the price more than they would for a larger company.

🟡 Key Things to WatchMeasurable tripwires, set against where this company stands today

1Free cash flow remains positive✗ not reported
Profit that never becomes cash eventually stops being profit.

Investment Checklist

4 / 8 checks passed

✗ Strong return on equity (ROE ≥ 15%)
✓ Healthy net margin (≥ 10%)
✓ Manageable leverage (Debt/Equity < 1.0)
✗ Revenue growing year-over-year
✗ Profit growing year-over-year
✓ Not trading at an extreme valuation (P/E < 40x)
✓ Not buying right at the 52-week high
✗ Short-term technical trend isn't bearish

Price history

Quick Metrics

2 good · 7 neutral · 2 weak

Market Cap

₹12 Cr

Micro Cap

Smaller company — thin liquidity and deep drawdowns are normal here

P/E (Trailing)

19.7x

Fair

Fairly valued against the generic band

P/B Ratio

2.20x

Fair

Moderate premium to the company's book value

EPS (TTM)

₹2.78

Profitable

Profitable on a per-share basis

ROE

11.2%

Moderate

Moderate capital efficiency

ROCE

Not available

No data

Source didn't return this field

Debt/Equity

0.53x

Low

Conservative leverage

Revenue Growth (YoY)

-1.2%

Shrinking

Sales are contracting

Profit Growth (YoY)

-20.3%

Falling

Profits are shrinking

Dividend Yield

None

No dividend yield reported — usually means no payout, but verify if one was recently initiated

Free Cash Flow

Not available

No data

Source didn't return this field

More Metrics

Operating Margin

242.2%

Good

Healthy core-business profitability

Net Margin

189.9%

Good

Strong bottom-line conversion

Beta (vs Nifty)

0.37

Defensive

Steadier than the market

52W Range Position

13%

Near low

Near its 52-week low

Technical Snapshot

SMA 20 / SMA 50

53.9 / 57.0

Bearish alignment (short < long)

Price vs SMA 200

Below

Long-term downtrend

RSI (14)

95.0

Overbought zone

Shareholding (proxy)

Institutional Holding

0.0%

Insider Holding

61.6%

Peer Comparison

Company	P/E	ROE
TATA CONSULTANCY SERV LT	17.3x	45.6%
INFOSYS LIMITED	15.8x	32.0%
HCL TECHNOLOGIES LTD	20.4x	24.6%
WIPRO LTD	14.5x	15.9%

Recent News

2 mixed1 negative3 general

Continental Chemicals shareholders approve Sunaina Chibba re-appointment at AGM

scanx.trade, 18 Sept

Continent Chem Standalone June 2026 Net Sales at Rs 0.06 crore, down 1.2% Y-o-Y

Moneycontrol.com, 18 Aug

Continental Chemicals reports no deviation in preferential issue fund utilization

scanx.trade, 11 AugFunding

🟡Mixed / dependsNew funding changes the capital structure. Debt raises leverage; an equity raise dilutes existing holders.

Univa Foods reports standalone net loss of Rs 0.05 crore in the June 2026 quarter

Business Standard, 11 AugResults

🟡Mixed / dependsA results event. The figures on this page update once the new statements reach the data feed, which usually lags the announcement.

Copper(II) Carbonate Basic Market

Future Market Insights, 01 Apr

Continental Chemicals Board Meeting on Jan 12 for Q3 Results, CFO Resignation

scanx.trade, 13 DecManagement

🔴Potentially negativeA senior departure, and an auditor's resignation especially, is worth understanding before anything else in this report.

Watch Items

Revenue growth is negative (-1.2%) on the latest reported period — check if this is one-off or a trend.
Cross-check against the company's latest quarterly filing / investor presentation before acting.
2 metrics couldn't be retrieved for this stock — this is more common for smaller or thinly-covered listings.
RSI is in overbought territory — momentum entries here carry more short-term pullback risk.

DalalBaazaar Thesis

StrongBusiness Quality · Financial Health · Profitability

MiddlingGrowth · Valuation · Risk

Points for each in the Score ↑

Good business at a fair price

A sound business at a reasonable valuation. Suitable for a long-term holding, with the valuation and the direction of margins worth watching rather than the business itself.

1 of 1 tripwires tripped — Free cash flow remains positive · see Key things to watch ↑